These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities. Martinelli I, Battaglioli T, Bucciarelli P, Passamonti SM, Mannucci PM. Circulation; 2004 Aug 03; 110(5):566-70. PubMed ID: 15262837 [Abstract] [Full Text] [Related]
3. Laboratory testing for heritable thrombophilia: impact on clinical management of thrombotic disease annotation. Greaves M, Baglin T. Br J Haematol; 2000 Jun 03; 109(4):699-703. PubMed ID: 10929018 [No Abstract] [Full Text] [Related]
4. Role of thrombophilia in deciding on the duration of anticoagulation. Bauer KA. Semin Thromb Hemost; 2004 Dec 03; 30(6):633-7. PubMed ID: 15630669 [Abstract] [Full Text] [Related]
7. Deep venous thrombosis of the upper extremity: is thrombophilia a relevant clinical issue? Hoffmann U, Spannagl M. Thromb Haemost; 2008 Sep 03; 100(3):369-70. PubMed ID: 18766248 [No Abstract] [Full Text] [Related]
8. Genetic susceptibility to venous thrombosis. Seligsohn U, Lubetsky A. N Engl J Med; 2001 Apr 19; 344(16):1222-31. PubMed ID: 11309638 [No Abstract] [Full Text] [Related]
9. Thrombophilia Testing and Venous Thrombosis. Connors JM. N Engl J Med; 2017 Sep 21; 377(12):1177-1187. PubMed ID: 28930509 [No Abstract] [Full Text] [Related]
10. [No indication for thrombophilia screening in patients with idiopathic venous thromboembolism and their relatives]. Middeldorp S, Prins MH, Büller HR. Ned Tijdschr Geneeskd; 2001 Jun 02; 145(22):1047-51. PubMed ID: 11414164 [Abstract] [Full Text] [Related]
11. [Hereditary thrombophilia and systemic sclerosis. An unusual case report]. Minenna G, Albanese L, D'Amore S, Scagliusi P, D'Amore M. Recenti Prog Med; 2007 Mar 02; 98(3):175-8. PubMed ID: 17484164 [Abstract] [Full Text] [Related]
16. Thrombophilia and women's health: An overview. Blickstein I. Obstet Gynecol Clin North Am; 2006 Sep 02; 33(3):347-56. PubMed ID: 16962913 [Abstract] [Full Text] [Related]
17. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives. Aznar J, Vayá A, Estellés A, Mira Y, Seguí R, Villa P, Ferrando F, Falcó C, Corella D, España F. Haematologica; 2000 Dec 02; 85(12):1271-6. PubMed ID: 11114134 [Abstract] [Full Text] [Related]
18. Hypercoagulable states in arterial and venous thrombosis: When, how, and who to test? Carroll BJ, Piazza G. Vasc Med; 2018 Aug 02; 23(4):388-399. PubMed ID: 30045685 [Abstract] [Full Text] [Related]
19. Normal prothrombin time in the presence of therapeutic levels of rivaroxaban. van Veen JJ, Smith J, Kitchen S, Makris M. Br J Haematol; 2013 Mar 02; 160(6):859-61. PubMed ID: 23278675 [No Abstract] [Full Text] [Related]
20. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation. De Stefano V, Martinelli I, Mannucci PM, Paciaroni K, Chiusolo P, Casorelli I, Rossi E, Leone G. N Engl J Med; 1999 Sep 09; 341(11):801-6. PubMed ID: 10477778 [Abstract] [Full Text] [Related] Page: [Next] [New Search]